Review
Published on 10 Jul 2025
Exploring the multifaceted roles of GLP-1 receptor agonists; a comprehensive review
in Diabetes Therapies
Frontiers in Clinical Diabetes and Healthcare
doi 10.3389/fcdhc.2025.1590530
- 515 views
Type at least 3 characters
19 articles
Original Research
Accepted on 04 Jul 2025
Association between eating behavior patterns and the therapeutic efficacy of GLP-1 receptor agonists in individuals with type 2 diabetes: A multicenter prospective observational study
in Diabetes Therapies
Frontiers in Clinical Diabetes and Healthcare
doi 10.3389/fcdhc.2025.1638681
- 333 views
Systematic Review
Published on 20 Jun 2025
A bibliometric analysis of global research hotspots and development trends in diabetic wound treatment
in Diabetes Therapies
Frontiers in Clinical Diabetes and Healthcare
doi 10.3389/fcdhc.2025.1603206
- 737 views
Original Research
Published on 10 Jun 2025
The status and trends of type 2 diabetic osteoporosis research: a global bibliometric and visualization analysis over the past 20 years
in Diabetes Therapies
Frontiers in Clinical Diabetes and Healthcare
doi 10.3389/fcdhc.2025.1596938
- 1,027 views
Original Research
Published on 16 Apr 2025
Design and methods of a multicenter randomized clinical trial of effects of diabetes-educated psychologist on glucose management and diabetes distress
in Diabetes Therapies
Frontiers in Clinical Diabetes and Healthcare
doi 10.3389/fcdhc.2025.1549234
- 890 views
Review
Published on 16 Apr 2025
Consumer-oriented review of digital diabetes prevention programs: insights from the CDC’s diabetes prevention recognition program
in Diabetes Therapies
Frontiers in Clinical Diabetes and Healthcare
doi 10.3389/fcdhc.2025.1562108
- 1,688 views
Original Research
Published on 24 Mar 2025
Exploring factors predicting the effectiveness of oral semaglutide in Japanese individuals with type 2 diabetes switching from dipeptidyl peptidase 4 inhibitors: a pilot study
in Diabetes Therapies
Frontiers in Clinical Diabetes and Healthcare
doi 10.3389/fcdhc.2025.1520389
- 1,525 views
Opinion
Published on 09 Jan 2025
GLP-1 receptor agonists in diabetes and weight loss: the double-edged sword of innovation and risks
in Diabetes Therapies
Frontiers in Clinical Diabetes and Healthcare
doi 10.3389/fcdhc.2024.1530811
- 3,002 views
- 2 citations
Case Report
Published on 19 Dec 2024
Inhibition of leukotrienes and their potential role in type 1 diabetes pathogenesis: implications for montelukast as a therapeutic agent: a case report
in Diabetes Therapies
Frontiers in Clinical Diabetes and Healthcare
doi 10.3389/fcdhc.2024.1494470
- 1,379 views
Editorial
Published on 22 Apr 2024
Editorial: Diabetes, transplantation and regenerative medicine
in Diabetes Therapies
Frontiers in Clinical Diabetes and Healthcare
doi 10.3389/fcdhc.2024.1388904
- 1,666 views
- 1 citation
Original Research
Published on 19 Apr 2024
Effect of metformin adjunct therapy on cardiometabolic parameters in Indian adolescents with type 1 diabetes: a randomized controlled trial
in Diabetes Therapies
Frontiers in Clinical Diabetes and Healthcare
doi 10.3389/fcdhc.2024.1353279
- 2,214 views
- 1 citation
Original Research
Published on 13 Nov 2023
Impact of GAD65 and IA2 autoantibodies on islet allograft survival
in Diabetes Therapies
Frontiers in Clinical Diabetes and Healthcare
doi 10.3389/fcdhc.2023.1269758
- 2,197 views
- 2 citations
Original Research
Published on 31 Aug 2023
Incidence and predictors of mortality in children with diabetic ketoacidosis in the comprehensive specialized referral hospitals of West Amhara Region, Northwest Ethiopia: a retrospective follow-up study
in Diabetes Therapies
Frontiers in Clinical Diabetes and Healthcare
doi 10.3389/fcdhc.2023.1204133
- 3,677 views
- 4 citations
Original Research
Published on 30 May 2023
The clinical implications of fasting serum insulin levels in patients with insulin-treated type 2 diabetes: a cross-sectional survey
in Diabetes Therapies
Frontiers in Clinical Diabetes and Healthcare
doi 10.3389/fcdhc.2023.1172208
- 3,966 views
Review
Published on 09 Mar 2023
Dopamine receptor agonists mechanism of actions on glucose lowering and their connections with prolactin actions
in Diabetes Therapies
Frontiers in Clinical Diabetes and Healthcare
doi 10.3389/fcdhc.2023.935872
- 8,697 views
- 14 citations
Original Research
Published on 03 Oct 2022
Aspalathin-rich green rooibos tea in combination with glyburide and atorvastatin enhances lipid metabolism in a db/db mouse model
in Diabetes Therapies
Frontiers in Clinical Diabetes and Healthcare
doi 10.3389/fcdhc.2022.963489
- 4,018 views
- 2 citations